» Articles » PMID: 38719446

Vagus Nerve Stimulation (VNS) Modulates Synaptic Plasticity in the Infralimbic Cortex Via Trk-B Receptor Activation to Reduce Drug-Seeking in Male Rats

Overview
Journal J Neurosci
Specialty Neurology
Date 2024 May 8
PMID 38719446
Authors
Affiliations
Soon will be listed here.
Abstract

Drugs of abuse cause changes in the prefrontal cortex (PFC) and associated regions that impair inhibitory control over drug-seeking. Breaking the contingencies between drug-associated cues and the delivery of the reward during extinction learning reduces relapse. Vagus nerve stimulation (VNS) has previously been shown to enhance extinction learning and reduce drug-seeking. Here we determined the effects of VNS-mediated release of brain-derived neurotrophic factor (BDNF) on extinction and cue-induced reinstatement in male rats trained to self-administer cocaine. Pairing 10 d of extinction training with VNS facilitated extinction and reduced drug-seeking behavior during reinstatement. Rats that received a single extinction session with VNS showed elevated BDNF levels in the medial PFC as determined via an enzyme-linked immunosorbent assay. Systemic blockade of tropomyosin receptor kinase B (TrkB) receptors during extinction, via the TrkB antagonist ANA-12, decreased the effects of VNS on extinction and reinstatement. Whole-cell recordings in brain slices showed that cocaine self-administration induced alterations in the ratio of AMPA and NMDA receptor-mediated currents in Layer 5 pyramidal neurons of the infralimbic cortex (IL). Pairing extinction with VNS reversed cocaine-induced changes in glutamatergic transmission by enhancing AMPAR currents, and this effect was blocked by ANA-12. Our study suggests that VNS consolidates the extinction of drug-seeking behavior by reversing drug-induced changes in synaptic AMPA receptors in the IL, and this effect is abolished by blocking TrkB receptors during extinction, highlighting a potential mechanism for the therapeutic effects of VNS in addiction.

References
1.
Childress A, Hole A, Ehrman R, Robbins S, McLellan A, OBrien C . Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr. 1993; 137:73-95. View

2.
Mathew E, Tabet M, Robertson N, Hays S, Rennaker R, Kilgard M . Vagus nerve stimulation produces immediate dose-dependent anxiolytic effect in rats. J Affect Disord. 2019; 265:552-557. DOI: 10.1016/j.jad.2019.11.090. View

3.
Dawson J, Liu C, Francisco G, Cramer S, Wolf S, Dixit A . Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial. Lancet. 2021; 397(10284):1545-1553. PMC: 8862193. DOI: 10.1016/S0140-6736(21)00475-X. View

4.
Olsen L, Moore R, Bechmann N, Ethridge V, Gargas N, Cunningham S . Vagus nerve stimulation-induced cognitive enhancement: Hippocampal neuroplasticity in healthy male rats. Brain Stimul. 2022; 15(5):1101-1110. DOI: 10.1016/j.brs.2022.08.001. View

5.
Follesa P, Biggio F, Gorini G, Caria S, Talani G, Dazzi L . Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. Brain Res. 2007; 1179:28-34. DOI: 10.1016/j.brainres.2007.08.045. View